|
|
killing by host of symbiont cells
|
GO:0051873 |
11 |
0.865
|
|
|
|
growth involved in symbiotic interaction
|
GO:0044110 |
23 |
0.660
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.648
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.647
|
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.624
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.575
|
Human |
|
|
cytokine production
|
GO:0001816 |
319 |
0.457
|
Human |
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.451
|
|
|
|
killing of cells in other organism involved in symbiotic interaction
|
GO:0051883 |
13 |
0.411
|
|
|
|
interaction with symbiont
|
GO:0051702 |
14 |
0.404
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.391
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.360
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.354
|
|
|
|
negative regulation of growth of symbiont in host
|
GO:0044130 |
19 |
0.354
|
|
|
|
disruption by host of symbiont cells
|
GO:0051852 |
11 |
0.347
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.343
|
|
|
|
defense response to fungus
|
GO:0050832 |
12 |
0.343
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.337
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.330
|
|
|
|
regulation of growth of symbiont in host
|
GO:0044126 |
19 |
0.325
|
|
|
|
negative regulation of growth of symbiont involved in interaction with host
|
GO:0044146 |
19 |
0.312
|
|
|
|
acute inflammatory response to antigenic stimulus
|
GO:0002438 |
12 |
0.309
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.300
|
Human |
|
|
growth of symbiont in host
|
GO:0044117 |
23 |
0.287
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.278
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.277
|
Human |
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.271
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.264
|
|
|
|
modulation of growth of symbiont involved in interaction with host
|
GO:0044144 |
19 |
0.248
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.244
|
Human |
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.242
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.228
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.228
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.220
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.219
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.218
|
|
|
|
killing of cells of other organism
|
GO:0031640 |
13 |
0.215
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.210
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.206
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.203
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.197
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.196
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.195
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.192
|
|
|
|
growth of symbiont involved in interaction with host
|
GO:0044116 |
23 |
0.184
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.180
|
Human |
|
|
skeletal system development
|
GO:0001501 |
356 |
0.173
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.171
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.169
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.162
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.161
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.160
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.157
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.156
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.156
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.152
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.152
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.149
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.142
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.141
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.136
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.133
|
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
4 |
0.131
|
|
|
|
neutrophil mediated killing of gram positive bacterium
|
GO:0070946 |
2 |
0.130
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.128
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.127
|
|
|
|
defense response to nematode
|
GO:0002215 |
4 |
0.127
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.119
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.119
|
|
|
|
innate immune response in mucosa
|
GO:0002227 |
3 |
0.113
|
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.113
|
|
|
|
neutrophil mediated immunity
|
GO:0002446 |
19 |
0.112
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.111
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.109
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.108
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.107
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.106
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.101
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.101
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.101
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.098
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.097
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.097
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.094
|
|
|
|
hydrogen peroxide catabolic process
|
GO:0042744 |
5 |
0.089
|
|
|
|
granzyme mediated apoptotic signaling pathway
|
GO:0008626 |
1 |
0.088
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.085
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.083
|
Human |
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.082
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.082
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.080
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.080
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.080
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.079
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.078
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.078
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.078
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.076
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.076
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.076
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.074
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.074
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.074
|
|
|
|
regulation of t cell costimulation
|
GO:2000523 |
2 |
0.073
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.073
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.072
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.072
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.072
|
|
|
|
regulation of chemokine production
|
GO:0032642 |
30 |
0.072
|
Human |
|
|
platelet activation
|
GO:0030168 |
40 |
0.070
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.070
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.070
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.070
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.069
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.068
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.067
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.066
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.065
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.065
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.065
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.064
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.064
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.064
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.064
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.064
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.064
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.063
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.063
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.062
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.061
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.061
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.061
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.060
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.060
|
Human |
|
|
membrane organization
|
GO:0061024 |
245 |
0.059
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.059
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.058
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.058
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.058
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.058
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.056
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.056
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.055
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.055
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.054
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.054
|
|
|
|
positive regulation of monocyte chemotaxis
|
GO:0090026 |
2 |
0.053
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.053
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.052
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.051
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.050
|
|
|
|
positive regulation of acute inflammatory response to non antigenic stimulus
|
GO:0002879 |
2 |
0.050
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.049
|
|
|
|
neutrophil mediated killing of fungus
|
GO:0070947 |
3 |
0.049
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
18 |
0.049
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.049
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.048
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.048
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.048
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.048
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.048
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.047
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.046
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.046
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.046
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.045
|
|
|
|
detection of light stimulus
|
GO:0009583 |
25 |
0.045
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.045
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.045
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.044
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.044
|
|
|
|
t helper 17 cell chemotaxis
|
GO:0035705 |
1 |
0.044
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.044
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.044
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.044
|
Human |
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.044
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.044
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.044
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.043
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.043
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.042
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.042
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.042
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.041
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.041
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.041
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.041
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.040
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.040
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.040
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.040
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.039
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.039
|
|
|
|
keratinocyte migration
|
GO:0051546 |
3 |
0.039
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.039
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.038
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.038
|
|
|
|
positive regulation of tumor necrosis factor biosynthetic process
|
GO:0042535 |
8 |
0.038
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.038
|
|
|
|
positive regulation of t cell extravasation
|
GO:2000409 |
2 |
0.037
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.037
|
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.037
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.037
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.037
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.037
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.037
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.036
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.036
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.036
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.036
|
|
|
|
positive regulation of cytokine biosynthetic process
|
GO:0042108 |
40 |
0.036
|
Human |
|
|
disruption of cells of other organism
|
GO:0044364 |
13 |
0.036
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.036
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.035
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.035
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.035
|
|
|
|
defense response to gram negative bacterium
|
GO:0050829 |
28 |
0.035
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.035
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.035
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.035
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.034
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.034
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.034
|
|
|
|
regulation of interleukin 4 production
|
GO:0032673 |
18 |
0.034
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.034
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.034
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.034
|
Human |
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.033
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.033
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.033
|
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.033
|
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.033
|
|
|
|
regulation of t cell mediated immunity
|
GO:0002709 |
34 |
0.033
|
|
|
|
central nervous system maturation
|
GO:0021626 |
6 |
0.032
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.032
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.032
|
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
2 |
0.032
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.032
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.032
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.032
|
|
|
|
regulation of interleukin 10 production
|
GO:0032653 |
21 |
0.032
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.032
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.032
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.032
|
|
|
|
interleukin 4 production
|
GO:0032633 |
24 |
0.031
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.031
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.031
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.031
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.031
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.031
|
|
|
|
positive regulation of immunological synapse formation
|
GO:2000522 |
1 |
0.031
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.031
|
|
|
|
ammonium transmembrane transport
|
GO:0072488 |
2 |
0.031
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.031
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.031
|
|
|
|
lipoxin a4 biosynthetic process
|
GO:2001303 |
1 |
0.030
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.030
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.030
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.030
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.030
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.030
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.030
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.030
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.030
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.030
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.029
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.029
|
|
|
|
positive regulation of histone h3 k9 methylation
|
GO:0051574 |
4 |
0.029
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.029
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.029
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.029
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.029
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.028
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.028
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.028
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.028
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.028
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.028
|
|
|
|
cellular response to superoxide
|
GO:0071451 |
14 |
0.028
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.028
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.027
|
|
|
|
eosinophil activation
|
GO:0043307 |
1 |
0.027
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.027
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.027
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.027
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.027
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.027
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.026
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.026
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.026
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.026
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.026
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.026
|
|
|
|
leukotriene metabolic process
|
GO:0006691 |
7 |
0.026
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.026
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.026
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.026
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.025
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.025
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.025
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.025
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.025
|
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.025
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.025
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.025
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.025
|
|
|
|
acetylcholine transport
|
GO:0015870 |
2 |
0.025
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.024
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.024
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.024
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.024
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.024
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.024
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.024
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.024
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.024
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.024
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.024
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.024
|
|
|
|
regulation of chloride transport
|
GO:2001225 |
2 |
0.024
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.024
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.024
|
|
|
|
interleukin 10 production
|
GO:0032613 |
23 |
0.024
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.024
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.024
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.024
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.024
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.024
|
|
|
|
antigen processing and presentation of peptide antigen
|
GO:0048002 |
29 |
0.024
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.023
|
|
|
|
eosinophil differentiation
|
GO:0030222 |
1 |
0.023
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.023
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.023
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.023
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.023
|
|
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.023
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.023
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.023
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.023
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.023
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.023
|
|
|
|
amino sugar catabolic process
|
GO:0046348 |
1 |
0.023
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.023
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.023
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.023
|
|
|
|
microglial cell activation involved in immune response
|
GO:0002282 |
1 |
0.023
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.023
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.023
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.023
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.023
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.023
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.023
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.023
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.023
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.023
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.022
|
|
|
|
antigen processing and presentation of exogenous antigen
|
GO:0019884 |
26 |
0.022
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.022
|
Human |
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.022
|
|
|
|
neutrophil mediated killing of symbiont cell
|
GO:0070943 |
8 |
0.022
|
|
|
|
phospholipid transfer to membrane
|
GO:0006649 |
2 |
0.022
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.022
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.022
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.022
|
|
|
|
hematopoietic stem cell migration
|
GO:0035701 |
1 |
0.022
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.022
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.022
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.022
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.022
|
|
|
|
iron ion transport
|
GO:0006826 |
17 |
0.022
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.021
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.021
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.021
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.021
|
|
|
|
cellular response to interleukin 15
|
GO:0071350 |
2 |
0.021
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.021
|
Human |
|
|
protein maturation
|
GO:0051604 |
176 |
0.021
|
|
|
|
negative regulation of interleukin 13 production
|
GO:0032696 |
2 |
0.021
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.021
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.021
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.021
|
|
|
|
fucosylation
|
GO:0036065 |
9 |
0.021
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.021
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.021
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.021
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.021
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.021
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.021
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.021
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.021
|
|
|
|
interleukin 1 secretion
|
GO:0050701 |
16 |
0.020
|
|
|
|
positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation
|
GO:2000526 |
1 |
0.020
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.020
|
|
|
|
cd8 positive alpha beta t cell extravasation
|
GO:0035697 |
3 |
0.020
|
|
|
|
response to mineralocorticoid
|
GO:0051385 |
1 |
0.020
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.020
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.020
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.020
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.020
|
|
|
|
interleukin 5 production
|
GO:0032634 |
10 |
0.020
|
|
|
|
regulation of granulocyte chemotaxis
|
GO:0071622 |
17 |
0.020
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.020
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.020
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.020
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.019
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.019
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.019
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.019
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.019
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.019
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.019
|
|
|
|
positive regulation of granulocyte chemotaxis
|
GO:0071624 |
12 |
0.019
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.019
|
|
|
|
bone trabecula morphogenesis
|
GO:0061430 |
12 |
0.019
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.019
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.019
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.019
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.019
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.019
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.019
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.019
|
|
|
|
positive regulation of interleukin 4 production
|
GO:0032753 |
15 |
0.019
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.019
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.018
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.018
|
|
|
|
positive regulation of jun kinase activity
|
GO:0043507 |
30 |
0.018
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.018
|
|
|
|
inorganic anion transport
|
GO:0015698 |
43 |
0.018
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.018
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.018
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.018
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.018
|
|
|
|
t cell mediated cytotoxicity
|
GO:0001913 |
26 |
0.018
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.018
|
|
|
|
eosinophil mediated immunity
|
GO:0002447 |
1 |
0.018
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.018
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.018
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.018
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.018
|
|
|
|
lipoxygenase pathway
|
GO:0019372 |
5 |
0.018
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.018
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.018
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.018
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.018
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.018
|
|
|
|
protein lipidation
|
GO:0006497 |
28 |
0.018
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.017
|
|
|
|
positive regulation of monocyte extravasation
|
GO:2000439 |
1 |
0.017
|
|
|
|
regulation of immunoglobulin mediated immune response
|
GO:0002889 |
37 |
0.017
|
|
|
|
immune complex clearance by monocytes and macrophages
|
GO:0002436 |
2 |
0.017
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.017
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.017
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.017
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.017
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.017
|
Human |
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.017
|
|
|
|
neutrophil mediated cytotoxicity
|
GO:0070942 |
8 |
0.017
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.017
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.017
|
|
|
|
establishment of skin barrier
|
GO:0061436 |
14 |
0.017
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.017
|
|
|
|
regulation of neutrophil chemotaxis
|
GO:0090022 |
14 |
0.017
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.017
|
|
|
|
dendritic cell differentiation
|
GO:0097028 |
26 |
0.017
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.017
|
|
|
|
negative regulation of adaptive immune response
|
GO:0002820 |
25 |
0.017
|
|
|
|
respiratory burst
|
GO:0045730 |
8 |
0.017
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.017
|
|
|
|
leukotriene biosynthetic process
|
GO:0019370 |
5 |
0.017
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.017
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.017
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.016
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.016
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.016
|
|
|
|
fatty acid derivative biosynthetic process
|
GO:1901570 |
15 |
0.016
|
|
|
|
negative regulation of interleukin 10 production
|
GO:0032693 |
8 |
0.016
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.016
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.016
|
|